 JERUSALEM, Feb. 22, 2022 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV, a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today announced that it will present a company overview at the Aegis Capital Corp. Virtual Conference on February 23rd at 9:30am ET. 